Evaluation of Ivermectin
In this brief, we recommend that ivermectin should be considered as a suitable candidate for early out-patient treatment for COVID-19, as well as a prophylactic.
In this brief, we recommend that ivermectin should be considered as a suitable candidate for early out-patient treatment for COVID-19, as well as a prophylactic.
Dr. David Chesler recounts the success he’s had treating nursing home patients with Ivermectin.
Dr Paul Marik provides protocols from the FLCCC for prevention and treatment of COVID-19 from outpatient to inpatient; it’s the ‘go to’ video for clarity
Slovakia Becomes the First EU Nation to Formally Approve Ivermectin for Both Prophylaxis and Treatment for COVID-19 Patients.
ENTER YOUR SEARCH TERMS AND HIT ENTER